Table 3 Cytotoxicity of PBH-capped AuNPs following 24- and 48-h exposure (EMEM/S-), using resazurin assay
From: Peptide-biphenyl hybrid-capped AuNPs: stability and biocompatibility under cell culture conditions
Exposure concentration (μg/ml) | |||||
---|---|---|---|---|---|
Exposure duration | AuNP | 12.5 | 25 | 50 | 100 |
Au[(Gly-Trp-Met)2B] | 24 h | 97 ± 1 | 97 ± 1* | 96 ± 1* | 94 ± 0.3**a |
Viability (%) | 48 h | 98 ± 1 | 98 ± 2 | 91 ± 1 | 69 ± 4**a |
Measured interference (%) | 96 ± 2 | 95 ± 2 | 94 ± 4 | 88 ± 4 | |
Au[(Gly-Tyr-TrCys) 2 B] | 24 h | 98 ± 1 | 96 ± 1* | 93 ± 1** | 90 ± 1** |
Viability (%) | 48 h | 95 ± 2 | 100 ± 2 | 95 ± 3 | 87 ± 2* |
Measured interference (%) | 96 ± 3 | 90 ± 6 | 85 ± 7 | 76 ± 6 | |
Au[(Gly-Tyr-Met)2B] | 24 h | 96 ± 1 | 96 ± 1* | 96 ± 1* | 91 ± 2**a |
Viability (%) | 48 h | 94 ± 1 | 91 ± 6* | 81 ± 6** | 71 ± 5**a |
Measured interference (%) | 95 ± 2 | 92 ± 2 | 90 ± 4 | 88 ± 4 | |
Au[(Met)2B] | 24 h | 97 ± 1 | 96 ± 0.4* | 93 ± 0.4** | 94 ± 2**a |
Viability (%) | 48 h | 97 ± 1 | 91* ± 3 | 88 ± 4** | 68 ± 4 **a |
Measured interference (%) | 93 ± 1 | 91± | 91 ± 2 | 89 ± 5 | |
Au[(TrCys)2B] | 24 h | 98 ± 1 | 97 ± 1 | 92 ±2* | 88 ± 1** |
Viability (%) | 48 h | 94 ± 4 | 93 ± 1 | 88 ± 2 ** | 77 ± 1** |
Measured interference (%) | 95 ± 1 | 93± | 91 ± 3 | 87 ± 4 |